Den europeiske union - norsk - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals for aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Den europeiske union - norsk - EMA (European Medicines Agency)

intervet international b.v. - celle-forbundet live rekombinant tyrkia herpes-virus (belastning hvp360), uttrykker fusion protein av nd-virus og vp2 protein av ibd virus - avian herpes virus (marek ' s sykdom) + avian smittsomme bursal disease virus (gumboro sykdom) + newcastle disease virus/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Den europeiske union - norsk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Norge - norsk - Statens legemiddelverk

recordati rare diseases - hemin, humant - konsentrat til infusjonsvæske, oppløsning - 25 mg/ ml

Den europeiske union - norsk - EMA (European Medicines Agency)

recordati rare diseases - cargluminsyre - amino acid metabolism, inborn errors; propionic acidemia - andre alimentary tract and metabolism products, - carbaglu er angitt i behandling av:hyperammonaemia på grunn av n-acetylglutamate-syntase primær mangel;hyperammonaemia på grunn av isovaleric acidaemia;hyperammonaemia på grunn av methymalonic acidaemia;hyperammonaemia på grunn av propionsyre acidaemia.

Den europeiske union - norsk - EMA (European Medicines Agency)

recordati rare diseases - betain vannfri - homocystinuria - andre alimentary tract and metabolism products, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Den europeiske union - norsk - EMA (European Medicines Agency)

recordati rare diseases - merkaptaminhydroklorid - cystinose - Øyemidler - cystadrop er indisert for behandling av hornhindecystinkrystaller hos voksne og barn fra 2 år med cystinose.

Den europeiske union - norsk - EMA (European Medicines Agency)

recordati rare diseases - merkaptaminbitartrat - cystinose - andre alimentary tract and metabolism products, - cystagon er indisert for behandling av bevist nefropatisk cystinose. cysteamin reduserer cystinakkumulering i enkelte celler (f.eks. leukocytter, muskel- og leverceller) hos nephropathic cystinosis-pasienter, og når behandlingen starter tidlig, forsinker det utviklingen av nyresvikt.

Den europeiske union - norsk - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - celleassosiert levende rekombinant kalkunherpesvirus (rhvt / nd) som uttrykker fusjonsproteinet av newcastle disease-virusen d-26 lentogen stamme - immunologicals for aves, live viral vaksiner - chicken; embryonated eggs - for aktive vaksinering av 18 dagers gammel embryonated kylling egg eller en-dag-gamle damer for å redusere dødelighet og kliniske tegn forårsaket av newcastle disease virus, og for å redusere dødelighet, kliniske tegn og lesjoner forårsaket av marek ' s disease virus med en phenotype "ondartet".

Den europeiske union - norsk - EMA (European Medicines Agency)

novartis europharm limited - ruxolitinib (som fosfat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastiske midler - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi er indisert for behandling av voksne pasienter med polycythaemia vera som er resistente mot eller intolerante av hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.